News

Exploring VitroPrime™: A Breakthrough in 3D Cell Culture

Exploring VitroPrime™: A Breakthrough in 3D Cell Culture

Introducing the Future of 3D Cell Culture

A groundbreaking design revolutionizes organoid culture by integrating high-resolution imaging within a single 3D culture plate.

The Well Bioscience has recently unveiled its innovative VitroPrime™ 3D Culture and Imaging Plate, setting a new standard for 3D cell culture workflows. This advanced plate has been thoughtfully designed to support organoid development while ensuring minimal physical disturbance during handling, allowing researchers to achieve reproducible results.

Revolutionary Features for Enhanced Research

One of the standout features of the VitroPrime™ plate is its unique in-plate design. This clever architecture enables long-term cell culture, sample fixation, and immunofluorescence performed without transferring samples, which can often lead to compromise of delicate 3D structures. With the ability to conduct high-resolution imaging directly in the same vessel, researchers can now observe their experiments without fear of losing their fragile samples.

Addressing Common Challenges in 3D Culturing

In traditional 3D cell culture setups, many researchers face significant hurdles including hydrogel floating, sample rotation, and overall sample loss, particularly during routine handling. The VitroPrime™ 3D Culture and Imaging Plate offers solutions to these persistent issues by minimizing manual intervention and vessel-to-vessel transfers. This not only enhances reproducibility but also supports longitudinal studies, allowing for consistent data collection across various phases of experimentation.

Many existing 3D culture systems are inadequate because they are designed for 2D growth rather than complex 3D constructs. This misalignment leads to disruption of spatial organization and architecture during regular media exchanges. Additionally, transferring samples for fixation or staining introduces the risk of damaging structures and altering the variability essential for accurate results, particularly for organoids that are time-consuming and challenging to produce.

A Comprehensive Solution for 3D Workflows

The VitroPrime™ 3D Culture and Imaging Plate offers a complete solution for a streamlined 3D workflow. Researchers can carry out sample seeding, long-term culturing, downstream processing, and imaging without transferring samples or disturbing the cellular architecture. This end-to-end approach drastically reduces the chances of error or loss, optimizing the workflow significantly.

John Huang, CEO of TheWell Bioscience, expressed the need for such innovation in the field: "We have engaged with researchers worldwide facing struggles in finding suitable culture vessels for 3D organoid workflows. Our years of design and developmental effort reflect our commitment to addressing these critical challenges through a practical solution. "

The Mechanisms Behind the Innovation

At the heart of the VitroPrime™ plate is a specialized lateral media exchange channel that facilitates the passive diffusion of essential nutrients, stains, and fixatives without disturbing the 3D constructs. The anti-floating design provides stability during various monitoring stages and imaging processes, while the ultra-clear premium cover-glass bottom allows for high-resolution and confocal imaging that meets the needs of today’s researchers.

Moreover, the VitroPrime™ integrates effortlessly into TheWell Bioscience's comprehensive 3D cell culture platform. Together with products like VitroGel® hydrogels, RocketCell™ media, and CytoGrow™ growth factors, it forms a scalable and automation-friendly setup, ensuring researchers can readily replicate and advance their studies.

Availability and Applications

The VitroPrime™ 3D Culture and Imaging Plate is offered in 6-, 12-, and 96-well formats, making it versatile for various research applications. This innovative product is paving the way for more reliable and reproducible advanced 3D cell models.

About TheWell Bioscience Inc.

TheWell Bioscience is dedicated to advancing the field of 3D cell cultures. Their end-to-end, xeno-free platform delivers an integrated suite of products that minimize animal-derived variability and cater to applications in precision medicine, cell therapy, and biomanufacturing. This commitment to human-relevant in vitro models is transforming biomedical research.

For inquiries or further information, please contact: Kyra Baricaua
9738554955

Frequently Asked Questions

What is the VitroPrime™ 3D Culture and Imaging Plate?

The VitroPrime™ is an innovative 3D cell culture plate that allows long-term culture and high-resolution imaging within a single vessel, minimizing sample transfer.

How does the VitroPrime™ plate improve 3D cell culture?

It addresses common challenges like hydrogel floating and sample loss, enhancing reproducibility by reducing manual handling and vessel changes.

In what formats is the VitroPrime™ available?

The product comes in 6-, 12-, and 96-well formats to cater to varying research needs.

Who can benefit from using the VitroPrime™ plate?

Researchers engaged in organoid studies and other 3D cell culture work will find this plate particularly beneficial for achieving better experimental outcomes.

What sets TheWell Bioscience apart in the industry?

The company is focused on delivering xeno-free products that enhance the reliability of 3D cell models, vital for advancing precision medicine and related fields.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Berney Flowers Rings the Bell on Fiscal Reform

Updated Category News Views 4

Berney Flowers: A Voice for Fiscal Change Oh boy, Berney Flowers sure isn't holding back. The Maryland congressional candidate is out here on Biz Talk Today TV, aiming straight at the heart of government waste and promising fiscal reform with the kind of intensity you don't see every day. Through the airwaves, he's been championing independent audits to keep those...

Continue Reading
SAGA Metals Strikes Potential with Wolverine Drilling Program

Updated Category News Views 8

Drilling for Treasure in Labrador's Rich Earth Hey, ever felt that gritty thrill in your bones? That's what I imagine SAGA Metals must be feeling right now. When you're out there punching holes into Mother Earth hoping to hit pay dirt, and every single one of those holes hits something juicy—trust me, that's like hitting the jackpot before even knowing the lottery...

Continue Reading
Ecology Auto Parts Faces Class Action for Labor Code Violations

Updated Category News Views 4

Legal Battle Unfolds: Employees Take a Stand Step right up, folks, and get a load of the latest legal rumble pitting employees against the big machine of Ecology Auto Parts, Inc. Operating out of California, these auto-wrecking giants are now staring down the barrel of a class action lawsuit alleging they're skimping on labor law essentials. The lawsuit, which the folks...

Continue Reading
UMC and AP Memory Boost Power with New AI Chips

Updated Category News Views 3

Breaking Ground in Data Center Power Every so often, the tech industry gets a jolt of innovation that turns heads—not just for what it can do today, but for what it promises tomorrow. This time, it's United Microelectronics Corporation (UMC) and AP Memory shaking things up with their collaboration aimed at redefining power delivery for AI and high-performance computing...

Continue Reading
Texas A&M-San Antonio Opens $55M Health Hub

Updated Category News Views 0

Building Blocks for Future Health Experts They say money talks, and down in San Antonio, it just shouted loud and clear. Texas A&M University-San Antonio sliced the ribbon on a $55 million Public Health and Education building, a step that isn’t just about bricks and mortar, but life-saving insights and hands-on training that'll ripple across South Texas. This isn’t...

Continue Reading
Doximity Lawsuit: Investors Face November Deadline

Updated Category News Views 5

Hard Knocks for Doximity Investors Alright, so this isn't the place I usually find myself at that hour, but we're living in wild times if you're clinging to Doximity (NYSE:DOCS) shares. Listen up, because those lawyers are chiming in and they ain't just whistling Dixie. If you bought into DOCS between August 2024 and May 2026 and watched your investment bleed red ink,...

Continue Reading
Annual Flu Shots May Save Lives: Accordia Health's Call

Updated Category News Views 3

Flu Season Isn't Just Sniffles: Accordia Health Speaks Up Listen up folks, it’s that time again and no, it ain’t just about digging out last year's scarf. Flu season is rolling in faster than a train outta hell, and already folks are talking about flu cases creeping up during the summer sunshine. We got Dr. Cameron Kilpatrick over at Accordia Health ringing the bell...

Continue Reading
Nuix debuts AI Agent with audit trail for added trust

Updated Category News Views 1

AI in Legal and Investigative Analysis: A Leap Forward Here comes Nuix with a shiny new toy—Nuix Neo AI Agent. And it ain't just any tool. This thing's built to dive through mountains of unstructured data and spit out answers backed by its trail of breadcrumbs. From legal teams to auditors and everyone in between, it'll lay out the paths it took to get to its...

Continue Reading
CGTN Introduces AI-Driven News Pal for Global Views

Updated Category News Views 2

News Pal: A New Spin on Global Reporting Folks in the newsroom are buzzing about CGTN’s fresh-faced brainchild, News Pal. This isn’t your run-of-the-mill news brief; we’re talking about a web-based AI contraption that’s flipping the script on how we digest the heap of headlines thrown at us every day. Launched mid-October, News Pal’s in the business of...

Continue Reading
Asuri.ai Unveils Multi-Agent AI Platform for Business

Updated Category News Views 4

Asuri.ai's Bold New Move into AI Workflows Picture the business world, bustling with nontechnical folks drowning in redundant tasks. Now toss a lifeline: Asuri.ai's fresh-off-the-presses multi-agent enterprise AI platform. This isn't just another tricked-out AI assistant; it's a serious game-changer on October 21, 2026. From Irvine, California, Asuri has kicked open a...

Continue Reading

Top 5 Most Recently Viewed Articles

Freeport-McMoRan Legal Update: Key Actions for Investors

Updated Category News Views 256

Understanding the Importance of Class Actions for Investors In the world of investing, class actions serve as crucial tools for holding companies accountable for their actions. Investors, particularly those who have purchased stocks during a defined time frame, like those involved with Freeport-McMoRan Inc. (NYSE: FCX), stand to benefit significantly from these legal...

Continue Reading
Investigation into ADMA Biologics Growth Potential and Risks

Updated Category News Views 58

Insights into ADMA Biologics and Ongoing Investigations Investors interested in ADMA Biologics, Inc. should be aware that the company is currently under investigation for potential securities fraud, prompting discussions about recovery options for those impacted. Understanding these developments can offer investors crucial insights into the company's future prospects and...

Continue Reading
Kuehn Law Assists Zentalis Pharmaceuticals Investors in Rights Endeavors

Updated Category News Views 82

Understanding Your Rights as a Zentalis Investor Kuehn Law, a prominent shareholder litigation firm, is currently investigating the actions of the management team at Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL). The focus lies on whether certain officers and directors have acted in ways that undermine their fiduciary responsibilities. These responsibilities include...

Continue Reading
Navigating Market Challenges: Insights into Recent Trends

Updated Category News Views 180

Understanding Current Market Dynamics In a time of significant market fluctuations, risk assets are facing pressure due to a complex mix of economic indicators and investor sentiment. Recent developments in US equities have created a landscape where volatility is the norm. This analysis will delve into various market segments, focusing on key events that shape the current...

Continue Reading
Harnessing Waste Heat: The Future of Clean Energy Deployment

Updated Category News Views 102

Harnessing Waste Heat to Drive Clean Energy Solutions ATS Energy, a trailblazer in renewable energy technology, is making significant strides in turning industrial waste heat into valuable electricity. This revolutionary process not only enhances energy efficiency but also contributes to a more sustainable future. The introduction of the bipartisan Waste Heat to Wattage...

Continue Reading